McKesson Ventures
  • Portfolio
  • News
    • In the News
    • Press Releases
  • Team
  • About Us
    • Our Approach
    • About McKesson
    • Contact Us

Dave Schulte Named as One of GrowthCap’s Top 25 Healthcare Investors of 2024

by McKesson Ventures | May 1, 2024 | Media Coverage

On May 1, 2024, growth investor and executive insights company GrowthCap named McKesson Ventures’ Managing Director Dave Schulte as one of its Top 25 Healthcare Investors of 2024. The list, published annually and founded in 2021, seeks to acknowledge individuals who...

McKesson Ventures’ Dave Schulte Named One of Healthcare’s Top 25 Investors

by McKesson Ventures | Jun 15, 2023 | Press Releases

McKesson Ventures Managing Director Dave Schulte has been recognized by GrowthCap as one of the top 25 healthcare investors for 2023. This award acknowledges healthcare investors who have demonstrated high levels of sustained investment performance and who are...

McKesson Appoints Tom Rodgers to Executive Vice President & Chief of Strategy and Business Development Officer

by McKesson Ventures | Jun 5, 2020 | Press Releases

McKesson Corporation announced that Tom Rodgers has been appointed executive vice president and chief strategy and business development officer, effective June 5, 2020. In his new role, Rodgers will also become a member of the company’s Executive Operating Team....
Personalized Medicine? We Still Have a Long Way to Go

Personalized Medicine? We Still Have a Long Way to Go

by McKesson Ventures | Mar 29, 2017 | Media Coverage

Near the end of Vator Splash Health, Wellness and Wearables, a group of venture capitalists took to the stage to discuss which healthtech trends VCs are embracing and which are overhyped. Participants included moderator Patrick Chung of Xfund and panelists Rebecca...

Recent Posts

  • CoverMyMeds Announces Acquisition of Companies RxLightning and FastAuth
  • Komodo Health Partners With Nasdaq to Deliver First Integrated Healthcare-Specialized Data Insights to the Financial Services Industry
  • Atropos Health Expands Oncology MultiModal Network in the Atropos Evidence Network with Addition of Ontada
  • Lumata Health Secures $23 Million Series B to Expand Access and Adherence to Vision-Saving Care
  • Mural Health and ICON Announce Partnership to Enhance Participant and Site Experience in Clinical Trials
McKesson Ventures

One Post Street, 21st Floor
San Francisco, CA 94104
USA

Contact Us

Cookie Settings

In the News

CoverMyMeds Announces Acquisition of Companies RxLightning and FastAuth

Komodo Health Partners With Nasdaq to Deliver First Integrated Healthcare-Specialized Data Insights to the Financial Services Industry

Atropos Health Expands Oncology MultiModal Network in the Atropos Evidence Network with Addition of Ontada

Lumata Health Secures $23 Million Series B to Expand Access and Adherence to Vision-Saving Care

©2025 McKesson Ventures | Privacy Notice | Disclaimer
  • Follow
  • Follow